60
Participants
Start Date
June 1, 2020
Primary Completion Date
April 1, 2022
Study Completion Date
April 1, 2022
Group Dexmedetomidine
Ropivacaine plus dexmedetomidine group
Group Ropivacaine
Plain ropivacaine group
Group Control
Control group
George Papanikolaou, General Hospital of Thessaloniki, Thessaloniki
Aretaieion University Hospital
OTHER